These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Thymoma with loss of keratin expression (and giant cells): a potential diagnostic pitfall. Adam P; Hakroush S; Hofmann I; Reidenbach S; Marx A; Ströbel P Virchows Arch; 2014 Sep; 465(3):313-20. PubMed ID: 24923897 [TBL] [Abstract][Full Text] [Related]
24. Ectopic cervical thymoma accompanied by Good's syndrome. Nagoya A; Kanzaki R; Nakagiri T; Inoue M; Susaki Y; Inoue S; Okumura M Ann Thorac Cardiovasc Surg; 2014; 20 Suppl():531-4. PubMed ID: 23364225 [TBL] [Abstract][Full Text] [Related]
25. The Co-Existence of Micronodular Thymoma and Lymphoma: A Clinicopathological and Immunohistochemical Study of Two Cases. Alqaidy D; Moran CA Int J Surg Pathol; 2023 Apr; 31(2):152-156. PubMed ID: 35469460 [TBL] [Abstract][Full Text] [Related]
26. Micro-RNA-16 expression in paraffin-embedded specimen correlates with overall survival of T-lymphoblastic lymphoma/leukemia. Xi Y; Li J; Zan L; Wang J; Wang G; Ning Y Hum Pathol; 2013 Jun; 44(6):1011-6. PubMed ID: 23260326 [TBL] [Abstract][Full Text] [Related]
27. Thymus and thymoma: what's new? Raica M; Encica S; Mogoanta L; Suciu C; Cîmpean AM; Margaritescu C Rom J Morphol Embryol; 1999-2004; 45():11-24. PubMed ID: 15847375 [TBL] [Abstract][Full Text] [Related]
28. Thymic hyperplasia and neoplasia: a review of current concepts. Levine GD; Rosai J Hum Pathol; 1978 Sep; 9(5):495-515. PubMed ID: 361541 [TBL] [Abstract][Full Text] [Related]
29. Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. Zhang J; McCastlain K; Yoshihara H; Xu B; Chang Y; Churchman ML; Wu G; Li Y; Wei L; Iacobucci I; Liu Y; Qu C; Wen J; Edmonson M; Payne-Turner D; Kaufmann KB; Takayanagi SI; Wienholds E; Waanders E; Ntziachristos P; Bakogianni S; Wang J; Aifantis I; Roberts KG; Ma J; Song G; Easton J; Mulder HL; Chen X; Newman S; Ma X; Rusch M; Gupta P; Boggs K; Vadodaria B; Dalton J; Liu Y; Valentine ML; Ding L; Lu C; Fulton RS; Fulton L; Tabib Y; Ochoa K; Devidas M; Pei D; Cheng C; Yang J; Evans WE; Relling MV; Pui CH; Jeha S; Harvey RC; Chen IL; Willman CL; Marcucci G; Bloomfield CD; Kohlschmidt J; Mrózek K; Paietta E; Tallman MS; Stock W; Foster MC; Racevskis J; Rowe JM; Luger S; Kornblau SM; Shurtleff SA; Raimondi SC; Mardis ER; Wilson RK; Dick JE; Hunger SP; Loh ML; Downing JR; Mullighan CG; Nat Genet; 2016 Dec; 48(12):1481-1489. PubMed ID: 27776115 [TBL] [Abstract][Full Text] [Related]
30. A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients. Oram SH; Thoms JA; Pridans C; Janes ME; Kinston SJ; Anand S; Landry JR; Lock RB; Jayaraman PS; Huntly BJ; Pimanda JE; Göttgens B Oncogene; 2010 Oct; 29(43):5796-808. PubMed ID: 20676125 [TBL] [Abstract][Full Text] [Related]
31. Cytopathology-histopathology of the mediastinum: epithelial, lymphoproliferative, and germ cell neoplasms. Wakely PE Ann Diagn Pathol; 2002 Feb; 6(1):30-43. PubMed ID: 11842377 [TBL] [Abstract][Full Text] [Related]
32. DNA methylation pattern is altered in childhood T-cell acute lymphoblastic leukemia patients as compared with normal thymic subsets: insights into CpG island methylator phenotype in T-ALL. Kraszewska MD; Dawidowska M; Larmonie NS; Kosmalska M; Sędek Ł; Szczepaniak M; Grzeszczak W; Langerak AW; Szczepański T; Witt M; Leukemia; 2012 Feb; 26(2):367-71. PubMed ID: 21836607 [No Abstract] [Full Text] [Related]
33. Precursor B-cell acute lymphoblastic leukemia after thymoma and myasthenia gravis: report of a case and review of the literature. Chang H; Chen TJ; Chuang WY; Lin TL Tumori; 2011; 97(1):126-9. PubMed ID: 21528677 [TBL] [Abstract][Full Text] [Related]
34. Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. Chilosi M; Doglioni C; Yan Z; Lestani M; Menestrina F; Sorio C; Benedetti A; Vinante F; Pizzolo G; Inghirami G Am J Pathol; 1998 Jan; 152(1):209-17. PubMed ID: 9422538 [TBL] [Abstract][Full Text] [Related]
35. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker. Nasr MR; Rosenthal N; Syrbu S Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257 [TBL] [Abstract][Full Text] [Related]
36. An unusual presentation of precursor T cell lymphoblastic leukemia/lymphoma with cholestatic jaundice: case report. Patel KJ; Latif SU; de Calaca WM J Hematol Oncol; 2009 Mar; 2():12. PubMed ID: 19284608 [TBL] [Abstract][Full Text] [Related]
37. Differentiating lymphoblastic lymphoma and Ewing's sarcoma: lymphocyte markers and gene rearrangement. Ozdemirli M; Fanburg-Smith JC; Hartmann DP; Azumi N; Miettinen M Mod Pathol; 2001 Nov; 14(11):1175-82. PubMed ID: 11706081 [TBL] [Abstract][Full Text] [Related]
38. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients]. Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455 [TBL] [Abstract][Full Text] [Related]
39. Cytarabine and EIP co-administration synergistically reduces viability of acute lymphoblastic leukemia cells with high ERG expression. Cheng L; Zeng S; Yan D; Tu L; Yang Y; Wang X; Zheng X Leuk Res; 2021 Oct; 109():106649. PubMed ID: 34271301 [TBL] [Abstract][Full Text] [Related]
40. T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiation. Dorfman DM; Morgan EA; Pelton A; Unitt C Hum Pathol; 2017 Jul; 65():166-174. PubMed ID: 28551327 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]